Difference between revisions of "Part:BBa K4180007"

Revision as of 03:34, 8 October 2022

pG1,10-snf1Δ381-633aa

This pG1,10-snf1Δ381-633aa is a composite biobrick. pGal1, 10-SPT5-Streptavidin Binding Protein(SBP) plasmid, containing 2u origin of replication (ORI) for yeast to start DNA replication, and ORI for bacteria DNA replication, was sponsored by Dr. Tien-Hsien Chang, at Genomics Research Center, Academia Sinica, in Taipei Taiwan. This plasmid can be transformed into bacteria and yeast, which was beneficial for our team to finish making biobricks in bacteria and perform the functional assay in yeast. Our team made 5 different basic parts (one promoter and 4 coding regions) and 4 different composite parts by inserting those 4 basic parts (BBa_K4180000, BBa_K4180002, BBa_K4180003, and BBa_K4180004) to replace the original SPT5 gene. pGal1,10-snf1Δ381-633, C-terminus truncated from amino acid381 to 633 deleting the autoinhibitory domain and SIP-interacting domain (SIR), losing the interaction with downstream of proteins.

Galactose promoter can be induced in the presence of galactose and suppressed in the presence of glucose (2,3)

Sequence and Features

<BBa_K4180007in BY4741 use SNF1-1 primers to do qPCR>

BBa_K4180007 composite site was SNF1 C-terminus truncated from amino acid381 to 633 deleting autoinhibitory domain and SIP-interacting domain (SIR) cloned downstream of the Gal1, 10 promoter. BBa_K4180007 composite site was transformed into BY4741 wild-type yeast strain. In the presence of 2%YP-galactose, SNF1 was only induced at least 2-fold at 17, and 24 hr, and 3.5-fold at 41 hr, which didn’t show if the BBa_K4180007 composite site was manipulated in the presence of galactose, compared to the induction in BBa_K4180008 control, since BBa_K4180007 composite site was not manipulated as much as what our team expected compared to the control of the SNF1 induction in BBa_K4180008. Compared to the endogenous SNF1 inBY4741, the SNF1 induction in BBa_K4180007 composite site was suppressed in the presence of galactose at those timecourses.

@@ Line 17: / Line 17: @@
 [[File:BBa K4180007in BY4741.jpeg|500px|]]
-Fig6: BBa_K4180007 composite site was SNF1 C-terminus truncated from amino acid381 to 633 deleting autoinhibitory domain and SIP-interacting domain (SIR) cloned downstream of the Gal1, 10 promoter. BBa_K4180007 composite site was transformed into BY4741 wild-type yeast strain. In the presence of 2%YP-galactose, SNF1 was only induced at least 2-fold at 17, and 24 hr, and 3.5-fold at 41 hr,which didn’t show if the BBa_K4180007 composite site was manipulated in the presence of galactose, compared to the induction in  BBa_K4180008 control, since BBa_K4180007 composite site was not manipulated as much as what our team expected compared to the control of the SNF1 induction in  BBa_K4180008 on fig 3. Compared to the fig 1, endogenous SNF1 inBY4741, the SNF1 induction in BBa_K4180007 composite site was suppressed in the presence of galactose at those timecourses.
+BBa_K4180007 composite site was SNF1 C-terminus truncated from amino acid381 to 633 deleting autoinhibitory domain and SIP-interacting domain (SIR) cloned downstream of the Gal1, 10 promoter. BBa_K4180007 composite site was transformed into BY4741 wild-type yeast strain. In the presence of 2%YP-galactose, SNF1 was only induced at least 2-fold at 17, and 24 hr, and 3.5-fold at 41 hr, which didn’t show if the BBa_K4180007 composite site was manipulated in the presence of galactose, compared to the induction in  BBa_K4180008 control, since BBa_K4180007 composite site was not manipulated as much as what our team expected compared to the control of the SNF1 induction in  BBa_K4180008. Compared to the endogenous SNF1 inBY4741, the SNF1 induction in BBa_K4180007 composite site was suppressed in the presence of galactose at those timecourses.
 <!-- Add more about the biology of this part here